While computational genomics methods have been greatly advanced by open development in distributed computing environments, computational tools for mass spectrometry proteomics remain tethered to proprietary and often outdated operating systems.…
Read More
A few years ago, we published a paper reporting PGBD5 as an oncogenic mutator in human cancer. This included measuring its expression in human tissues and mapping its association with…
Read MoreGenetically engineered mouse models of human cancers have proven to be essential for the elucidation of basic molecular mechanisms of cancer pathogenesis and their therapeutic targeting. However, for many genetic…
Read MoreDysregulated control of gene expression is probably one of the essential features of almost every cancer. The causes of this phenomenon vary, but emerging research is converging on the idea…
Read MoreAs we and others have described recently, modern mass spectrometry permits quantitative and sensitive measurements of both protein abundance and their chemical modifications, as proxies of biological and pathological activities.…
Read MoreOutstanding talk by Dr. Alex Kentsis @KentsisResearch describing his work using novel genomic and proteomic approaches for cancer therapy, including #leukemia #leusm @sloan_kettering @WeillCornell
2Improved protein structure prediction using potentials from deep learning https://t.co/o7KdQywMn1
@JaroszLab : A Non-amyloid Prion Particle that Activates a Heritable Gene Expression Program https://t.co/JwLBU3TaDA
Engraftment of rare, pathogenic donor hematopoietic mutations in unrelated hematopoietic stem cell transplantation https://t.co/A8lyzHSshY
